STOCK TITAN

Opgen Inc - OPGN STOCK NEWS

Welcome to our dedicated news page for Opgen (Ticker: OPGN), a resource for investors and traders seeking the latest updates and insights on Opgen.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Opgen's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Opgen's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
84.8%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.73%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.28%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.29%
Tags
offering
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.39%
Tags
clinical trial
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-24.14%
Tags
offering
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.88%
Tags
none
Opgen Inc

Nasdaq:OPGN

OPGN Rankings

OPGN Stock Data

6.96M
9.97M
0.42%
2.68%
0.21%
Medical Laboratories
Health Care and Social Assistance
Link
US
Gaithersburg

About OPGN

opgen, inc. (nasdaq: opgn) is harnessing the power of informatics and genomic analysis to provide complete solutions for infection prevention and treatment. using our large and ever-growing acuitas lighthouse® knowledgebase of pathogens from around the world, we are developing disruptive technologies aimed to shift the paradigm for managing infectious diseases. today, through our clia-certified clinical laboratory services, we provide rapid detection and analysis of antibiotic resistance and high resolution microbial sequence analysis. our fda-cleared, ivd products rapidly identify pathogens in positive blood cultures.